EODData

MEMBERSHIP REGISTER LOG IN

FRA, 1B1: ONCOARENDI THERAP ZY-01

03 Sep 2025
LAST:

1.734

CHANGE:
 0.00		OPEN:
1.734		HIGH:
1.734		ASK:
0.000		VOLUME:
0
CHG(%):
0.12		PREV:
1.736		LOW:
1.734		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
03 Sep 251.7341.7341.7341.7340
02 Sep 251.7361.7361.7361.7360
01 Sep 251.7421.7421.7421.7420
29 Aug 251.7761.7761.7761.7760
28 Aug 251.7821.7821.7821.7820
27 Aug 251.7781.7781.7781.7780
26 Aug 251.7901.7901.7901.7900
25 Aug 251.7901.7901.7901.7900
22 Aug 251.8061.8061.8061.8060
21 Aug 251.7861.7861.7861.7860

COMPANY PROFILE

Name:ONCOARENDI THERAP ZY-01
About:Molecure S.A., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of neoplastic and inflammatory diseases in Poland. The company is involved in the development of OATD-01, a chitotriosidase/AMCASE inhibitor that has completed phase I clinical trial for the treatment of sarcoidosis, as well as in preclinical stage to treat idiopathic pulmonary fibrosis and NASH. It also develops OATD-02, an arginase 1 and arginase 2, which is in Phase I clinical trial for the treatment of cancer; USP7, USP21, and YKL-40 for the treatment of cancer; and Deubiquitinase program. The company was formerly known as OncoArendi Therapeutics S.A. and changed its name to Molecure S.A. in March 2022. Molecure S.A. was founded in 2012 and is headquartered in Warsaw, Poland.
Sector:Healthcare
Industry:Biotechnology
Address:Zwirki i Wigury 101, Warsaw, Poland, 02-089
Website:https://molecure.com
ISIN:PLONCTH00011
LEI:2594003L11V38ZCVKZ09

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:1.75
MA10:1.77
MA20:1.79
MA50:1.61
MA100:1.66
MA200:1.91
RSI14:30.34
WPR14:-100.00
MTM14:-0.07
ROC14:-0.04
ATR:0.01
Week High:1.78
Week Low:1.73
Month High:1.93
Month Low:1.73
Year High:3.55
Year Low:1.23